The increased expression of ATP13A4 (breast cancer), ATP13A3 (pancreatic and neuroblastoma cancers), and SLC3A2/SLC7A5 (LAT1) in various cancers suggest their potential as therapeutic targets through the inhibition of polyamine transport. Here, SLC7A5 is linked to breast cancer.